Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

NicVAX for Nicotine Addiction

Drug (Brand / Generic)

NicVAX (Nicotine Conjugate Vaccine)

Company / Licensee

Nabi Biopharmaceuticals

Therapy Class

Active Immunotherapeutics

Product Description

Hapten 3'-aminomethylnicotine conjugated to exoprotein A.

Current Indication

Treats nicotine addiction and prevention of smoking relapse.

Market Sector

Respiratory system.

Development Status

Phase III
Expand
Close
Close
Close

Go Top